Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
120
-
Total 13F shares, excl. options
-
191M
-
Shares change
-
+45.7M
-
Total reported value, excl. options
-
$438M
-
Value change
-
+$105M
-
Put/Call ratio
-
10.02
-
Number of buys
-
78
-
Number of sells
-
-28
-
Price
-
$2.29
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2023
133 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2023.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 191M shares
of 363M outstanding shares and own 52.67% of the company stock.
Largest 10 shareholders include Artal Group S.A. (118M shares), BVF INC/IL (20M shares), FMR LLC (8.51M shares), VANGUARD GROUP INC (6.46M shares), BlackRock Inc. (6.38M shares), JPMORGAN CHASE & CO (2.93M shares), MILLENNIUM MANAGEMENT LLC (2.63M shares), NEA Management Company, LLC (2.38M shares), PINNACLE ASSOCIATES LTD (1.99M shares), and Octagon Capital Advisors LP (1.92M shares).
This table shows the top 120 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.